TH17 cells produce the effector cytokines IL-17A, IL-17F, IL-22, and GM-CSF to mediate pathological inflammation responsible for many types of autoimmune diseases; targeting TH17 cells is thus a potential treatment for these diseases45. The gene discussed is CSF2; the disease is autoimmune disease.